| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $473.6M | +21.4% |
| Cost of Revenue | $69.8M | +17.6% |
| Gross Profit | $403.8M | +22.1% |
| R&D Expense | $177.9M | +29.0% |
| SG&A Expense | $72.1M | +17.7% |
| Operating Income | -$121.2M | -22.8% |
| Pre-tax Income | -$110.8M | +0.0% |
| Income Tax | $13.7M | +127.5% |
| Net Income | -$124.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $367.8M | -54.4% |
| Short-term Investments | $236.3M | — |
| Accounts Receivable | $136.0M | +16.0% |
| Current Assets | $905.7M | -5.6% |
| Total Assets | $1.04B | -5.8% |
| Current Liabilities | $228.7M | +8.0% |
| Stockholders' Equity | $502.1M | -15.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.9M | +65.4% |
| Capital Expenditures | $11.4M | +8.6% |
| Investing Cash Flow | -$374.3M | -788.2% |
| Financing Cash Flow | -$75.6M | -114.8% |
| Free Cash Flow | $475K | +114.3% |
| -6.6% |
| EPS (Basic) | -$1.14 | -2.7% |
| EPS (Diluted) | -$1.14 | -2.7% |